Ozempic Maker Novo Nordisk to Cut 9,000 Jobs
The Danish drugmaker said it needed to streamline operations and become more agile, as it faces a more competitive and consumer-focused market.
The Danish drugmaker said it needed to streamline operations and become more agile, as it faces a more competitive and consumer-focused market.
Copyright © Todos los derechos reservados | Desarrollado por Interweb Ec
